enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Non-invasive ventilation - Wikipedia

   en.wikipedia.org/wiki/Non-invasive_ventilation

   Non-invasive ventilation is used in acute respiratory failure caused by a number of medical conditions, most prominently chronic obstructive pulmonary disease (COPD); numerous studies have shown that appropriate use of NIV reduces the need for invasive ventilation and its complications. Furthermore, it may be used on a long-term basis in people ...

3. How To Be Active in Your Treatment Journey With COPD - AOL

   www.aol.com/active-treatment-journey-copd...

   Since COPD is a progressive disease, symptoms often evolve over time, and it’s important for patients to monitor and effectively communicate changes and the impact of symptoms to their doctor.

4. Flow-restricted, oxygen-powered ventilation device - Wikipedia

   en.wikipedia.org/wiki/Flow-restricted,_oxygen...

   The device must have a pressure relief valve that opens at 60cm of water pressure to avoid over ventilation and trauma to the lungs. The (FROPVD) is contraindicated in adult patients with potential chest trauma and all children. Note: ( In cases with an apneic patient the best results will be achieved using the Two person bag-valve-mask technique.)

5. Dry-powder inhaler - Wikipedia

   en.wikipedia.org/wiki/Dry-powder_inhaler

   A dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin) have also been used in the treatment of diabetes mellitus. [1]

6. How to Exercise When You Have COPD - AOL

   www.aol.com/exercise-copd-143308318.html

   While a COPD patient’s exercise won’t improve the inner workings of their lungs, it does make breathing and daily activities easier by increasing cardio fitness and strengthening muscles ...

7. US FDA approves Verona Pharma's inhaled COPD therapy - AOL

   www.aol.com/news/us-fda-approves-verona-pharmas...

   The add-on COPD drug market is seeing interest from larger drugmakers as well, especially Regeneron and Sanofi's blockbuster anti-inflammatory drug Dupixent, although the FDA extended its review ...